GlobeNewswire Inc.··Levi & Korsinsky, LlpNektar Therapeutics Faces Securities Fraud Suit Over Clinical Trial Protocol Violations
Nektar Therapeutics faces securities class action lawsuit alleging REZOLVE-AA trial enrolled four ineligible patients, masking disappointing efficacy results.
NKTRsecurities fraudclass action lawsuit